Amarin Corp Plc (AMRN)

[ziploc_1]

The solution to the Vascepa four doses a day problem may lie with MND-2119 and a FDC with a statin(reducing five pills a day to one per day)...Thus far, we have not been made privy to any details about the Amarin agreement with Mochida, which would make such products practical for Amarin to produce and market worldwide...nor do we really know much about Amarin's intentions along this line.

We do know that MND-2119 can be marketed worldwide except in Japan...but we don't know whether Amarin would be on the hook for royalties to be paid to Mochida.